181 related articles for article (PubMed ID: 22041899)
1. Dual specificity of anti-CXCL10-CXCL9 antibodies is governed by structural mimicry.
Fagète S; Rousseau F; Magistrelli G; Gueneau F; Ravn U; Kosco-Vilbois MH; Fischer N
J Biol Chem; 2012 Jan; 287(2):1458-67. PubMed ID: 22041899
[TBL] [Abstract][Full Text] [Related]
2. Modelling of the membrane receptor CXCR3 and its complexes with CXCL9, CXCL10 and CXCL11 chemokines: putative target for new drug design.
Trotta T; Costantini S; Colonna G
Mol Immunol; 2009 Dec; 47(2-3):332-9. PubMed ID: 19800124
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-27 and IFNγ regulate the expression of CXCL9, CXCL10, and CXCL11 in hepatitis.
Basset L; Chevalier S; Danger Y; Arshad MI; Piquet-Pellorce C; Gascan H; Samson M
J Mol Med (Berl); 2015 Dec; 93(12):1355-67. PubMed ID: 26199110
[TBL] [Abstract][Full Text] [Related]
4. Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo.
Aguilera-Durán G; Romo-Mancillas A
Molecules; 2020 Sep; 25(19):. PubMed ID: 32992956
[TBL] [Abstract][Full Text] [Related]
5. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
[TBL] [Abstract][Full Text] [Related]
6. Interferons induce CXCR3-cognate chemokine production by human metastatic melanoma.
Dengel LT; Norrod AG; Gregory BL; Clancy-Thompson E; Burdick MD; Strieter RM; Slingluff CL; Mullins DW
J Immunother; 2010; 33(9):965-74. PubMed ID: 20948440
[TBL] [Abstract][Full Text] [Related]
7. Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4
Hart M; Nickl L; Walch-Rueckheim B; Krammes L; Rheinheimer S; Diener C; Taenzer T; Kehl T; Sester M; Lenhof HP; Keller A; Meese E
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33229509
[TBL] [Abstract][Full Text] [Related]
8. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
[TBL] [Abstract][Full Text] [Related]
9. Review: The chemokine receptor CXCR3 and its ligands CXCL9, CXCL10 and CXCL11 in neuroimmunity--a tale of conflict and conundrum.
Müller M; Carter S; Hofer MJ; Campbell IL
Neuropathol Appl Neurobiol; 2010 Aug; 36(5):368-87. PubMed ID: 20487305
[TBL] [Abstract][Full Text] [Related]
10. Desiccating stress-induced chemokine expression in the epithelium is dependent on upregulation of NKG2D/RAE-1 and release of IFN-γ in experimental dry eye.
Coursey TG; Bohat R; Barbosa FL; Pflugfelder SC; de Paiva CS
J Immunol; 2014 Nov; 193(10):5264-72. PubMed ID: 25288568
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of Cxcr3 and its ligands, Cxcl9 and Cxcl10, during the development of alopecia areata in the mouse.
McPhee CG; Duncan FJ; Silva KA; King LE; Hogenesch H; Roopenian DC; Everts HB; Sundberg JP
J Invest Dermatol; 2012 Jun; 132(6):1736-8. PubMed ID: 22358057
[No Abstract] [Full Text] [Related]
12. [Expressions of CXCL9, CXCL10 and CXCL11 in renal tubular epithelial cells induced by IFN-γ].
Lin Q; Song Y; Zhu X; Yang S; Zheng J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Feb; 29(2):137-40. PubMed ID: 23388331
[TBL] [Abstract][Full Text] [Related]
13. The prognostic importance of CXCR3 chemokine during organizing pneumonia on the risk of chronic lung allograft dysfunction after lung transplantation.
Shino MY; Weigt SS; Li N; Palchevskiy V; Derhovanessian A; Saggar R; Sayah DM; Huynh RH; Gregson AL; Fishbein MC; Ardehali A; Ross DJ; Lynch JP; Elashoff RM; Belperio JA
PLoS One; 2017; 12(7):e0180281. PubMed ID: 28686641
[TBL] [Abstract][Full Text] [Related]
14. Proteolytic chemokine cleavage as a regulator of lymphocytic infiltration in solid tumors.
Bronger H; Magdolen V; Goettig P; Dreyer T
Cancer Metastasis Rev; 2019 Sep; 38(3):417-430. PubMed ID: 31482487
[TBL] [Abstract][Full Text] [Related]
15. Bu-Shen-Fang-Chuan formula attenuates T-lymphocytes recruitment in the lung of rats with COPD through suppressing CXCL9/CXCL10/CXCL11-CXCR3 axis.
Li Q; Sun J; Cao Y; Liu B; Li L; Mohammadtursun N; Zhang H; Dong J; Wu J
Biomed Pharmacother; 2020 Mar; 123():109735. PubMed ID: 31864210
[TBL] [Abstract][Full Text] [Related]
16. The Serum Level of CXCL9, CXCL10, and CXCL11 and the Expression of CXCR3 of Peripheral Blood Mononuclear Cells in Brucellosis Patients.
Hassanshahi F; Noroozi Karimabad M; Miranzadeh E; Hassanshahi G; Torabizadeh SA; Jebali A
Curr Microbiol; 2023 May; 80(6):201. PubMed ID: 37140634
[TBL] [Abstract][Full Text] [Related]
17. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
[TBL] [Abstract][Full Text] [Related]
18. Citrullination of CXCL10 and CXCL11 by peptidylarginine deiminase: a naturally occurring posttranslational modification of chemokines and new dimension of immunoregulation.
Loos T; Mortier A; Gouwy M; Ronsse I; Put W; Lenaerts JP; Van Damme J; Proost P
Blood; 2008 Oct; 112(7):2648-56. PubMed ID: 18645041
[TBL] [Abstract][Full Text] [Related]
19. Common variants of chemokine receptor gene CXCR3 and its ligands CXCL10 and CXCL11 associated with vascular permeability of dengue infection in peninsular Malaysia.
Hoh BP; Umi-Shakina H; Zuraihan Z; Zaiharina MZ; Rafidah-Hanim S; Mahiran M; Khairudin NY; Benedict LH; Masliza Z; Christopher KC; Sazaly AB
Hum Immunol; 2015 Jun; 76(6):421-6. PubMed ID: 25858769
[TBL] [Abstract][Full Text] [Related]
20. Cloning, expression and characterization of ferret CXCL10.
Danesh A; Seneviratne C; Cameron CM; Banner D; Devries ME; Kelvin AA; Xu L; Ran L; Bosinger SE; Rowe T; Czub M; Jonsson CB; Cameron MJ; Kelvin DJ
Mol Immunol; 2008 Mar; 45(5):1288-97. PubMed ID: 18006061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]